Autoradiographic analysis of regional alterations in brain receptors following chronic administration and withdrawal of typical and atypical neuroleptics in rats
- PMID: 1977417
- DOI: 10.1007/BF01245166
Autoradiographic analysis of regional alterations in brain receptors following chronic administration and withdrawal of typical and atypical neuroleptics in rats
Abstract
Rats were administered haloperidol, clozapine, raclopride, or no drug for 28 days or 8 months. Following a 3 week withdrawal period, in vitro autoradiography was utilized to examine receptor binding for dopamine D2 ([3H]spiperone and [3H]raclopride), dopamine D 1 ([3H]SCH23390), GABA(A) ([3H]muscimol), benzodiazepine ([3H]RO15-1788), and muscarinic ACh receptors ([3H]QNB). [3H]spiperone was elevated in striatal subregions only in haloperidol-treated rats, with the largest increases seen in the 8 month duration animals. Striatal [3H]raclopride binding was increased after both short- and long-term treatment in both haloperidol and raclopride, but not clozapine-treated animals. Clozapine-treated rats showed significant increases in [3H]SCH23390 in the nucleus accumbens after 28-day administration; otherwise no changes were seen for this ligand in any other groups. Increases in [3H]muscimol binding in the substantia nigra reticulata were seen in haloperidol-treated rats after 8 month treatment. Binding of [3H]QNB and [3H]RO151788 were not significantly different from control for any of the drug-treated groups. These data suggest that persisting alterations in receptor binding are primarily seen in dopamine D2 and GABA receptors after withdrawal from chronic administration of haloperidol but not the atypical neuroleptics, clozapine and raclopride.
Similar articles
-
Dopamine receptor subtypes: differential regulation after 8 months treatment with antipsychotic drugs.J Pharmacol Exp Ther. 1997 Feb;280(2):561-9. J Pharmacol Exp Ther. 1997. PMID: 9023264
-
Differential regulation of dopamine receptors after chronic typical and atypical antipsychotic drug treatment.Neuroscience. 1997 Jun;78(4):985-96. doi: 10.1016/s0306-4522(96)00631-8. Neuroscience. 1997. PMID: 9174067
-
Regulation of ionotropic glutamate receptors following subchronic and chronic treatment with typical and atypical antipsychotics.Psychopharmacology (Berl). 1996 Dec;128(4):371-9. doi: 10.1007/s002130050147. Psychopharmacology (Berl). 1996. PMID: 8986008
-
Atypical neuroleptics have low affinity for dopamine D2 receptors or are selective for D4 receptors.Neuropsychopharmacology. 1997 Feb;16(2):93-110; discussion 111-35. doi: 10.1016/S0893-133X(96)00187-X. Neuropsychopharmacology. 1997. PMID: 9015795 Review.
-
Effects of long-term administration of antidepressants and neuroleptics on receptors in the central nervous system.Cell Mol Neurobiol. 1989 Mar;9(1):1-44. doi: 10.1007/BF00711441. Cell Mol Neurobiol. 1989. PMID: 2565769 Free PMC article. Review.
Cited by
-
Decreased M1 muscarinic receptor density in rat amphetamine model of schizophrenia is normalized by clozapine, but not haloperidol.J Neural Transm (Vienna). 2008 Nov;115(11):1563-71. doi: 10.1007/s00702-008-0122-8. Epub 2008 Sep 20. J Neural Transm (Vienna). 2008. PMID: 18806925
-
Early-life risperidone alters locomotor responses to apomorphine and quinpirole in adulthood.Behav Brain Res. 2024 Sep 13;473:115171. doi: 10.1016/j.bbr.2024.115171. Epub 2024 Jul 31. Behav Brain Res. 2024. PMID: 39094954
-
Oral movement patterns induced in rats by local infusions into striatum depend upon the regimen of prior neuroleptic exposure.Psychopharmacology (Berl). 1995 Sep;121(2):259-66. doi: 10.1007/BF02245637. Psychopharmacology (Berl). 1995. PMID: 8545532
-
A common action of clozapine, haloperidol, and remoxipride on D1- and D2-dopaminergic receptors in the primate cerebral cortex.Proc Natl Acad Sci U S A. 1994 May 10;91(10):4353-6. doi: 10.1073/pnas.91.10.4353. Proc Natl Acad Sci U S A. 1994. PMID: 8183912 Free PMC article.
-
Mechanisms of action of atypical antipsychotic drugs: a critical analysis.Psychopharmacology (Berl). 1996 Mar;124(1-2):2-34. doi: 10.1007/BF02245602. Psychopharmacology (Berl). 1996. PMID: 8935797 Review.